Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL110360 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL29609979 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL30552890 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL483413 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL29397925 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| Hydrochloric Acid SCHEMBL27389834 | 0.98 | UGT2B7 (0.96) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL10785006 | 0.93 | UGT2B7 (0.88) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL5610446 | 0.91 | UGT2B7 (0.82) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| Acetic Acid SCHEMBL7514323 | 0.90 | UGT2B7 (0.81) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL3151796 | 0.84 | UGT2B7 (0.73) | UGT2B7MEN1KMT2AATMCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018094293-A1 | A KIT FOR DETERMINING THE ABSOLUTE CONFIGURATION OF ALCOHOLS USING A COMPETING ENANTIOSELECTIVE CONVERSION APPROACH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-24 | — | — | WO | claimed |
| US-20240248028-A1 | QUANTITATIVE CHIRALITY AND CONCENTRATION SENSING OF CHIRAL ANALYTES USING QUINONES, (HETERO)ARYL ISOCYANATES, AND/OR (HETERO)ARYL ISOTHIOCYANATES | GEORGETOWN UNIVERSITY | 2024-07-25 | — | — | US | disclosed |
| WO-2022216359-A1 | QUANTITATIVE CHIRALITY AND CONCENTRATION SENSING OF CHIRAL ANALYTES USING QUINONES, ( HETERO)ARYL ISOCYANATES, AND/OR (HETERO)ARYL ISOTHIOCYANATES | GEORGETOWN UNIVERSITY (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2018094293-A1 | A KIT FOR DETERMINING THE ABSOLUTE CONFIGURATION OF ALCOHOLS USING A COMPETING ENANTIOSELECTIVE CONVERSION APPROACH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-24 | — | — | WO | disclosed |
| US-9969739-B2 | Tricyclic chiral compounds and their use in asymmetric catalysis | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-05-15 | — | — | US | disclosed |
| US-9969739-B2 | Tricyclic chiral compounds and their use in asymmetric catalysis | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-05-15 | — | — | US | disclosed |
| US-9631205-B2 | Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same | SANYO FOODS CO., LTD. (JP) | 2017-04-25 | — | — | US | disclosed |
| US-9556457-B2 | Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same | SANYO FOODS CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20160207932-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | UNIV NANYANG TECH (SG) | 2016-07-21 | — | — | US | disclosed |
| US-20160207932-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | UNIV NANYANG TECH (SG) | 2016-07-21 | — | — | US | disclosed |
| US-6596887-B2 | Reacting a ruthenium-phosphine complex with a specific optically active chiral diamine to deactivate one of the enantiomers and with another diamine to activate the other enantiomers | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-07-22 | — | — | US | disclosed |
| US-20030125590-A1 | Fluorous triphase and other multiphase systems | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-03 | — | — | US | disclosed |
| US-20030078444-A1 | Fluorous triphase and other multiphase systems | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-24 | — | — | US | disclosed |
| WO-2002100802-A2 | FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS | UNIVERSITY OF PITTSBURGH (US) | 2002-12-19 | — | — | WO | disclosed |
| US-20010039354-A1 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-08 | — | — | US | disclosed |
| EP-1134226-A2 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | Takasago International Corporation (JP) | 2001-09-19 | — | — | EP | disclosed |
| US-6218581-B1 | SOLVENT EXTRACTION OF WATER SOLUBLE PROTEIN FROM BEAN OR GRAIN; ISOLATION, PURIFICATION OF ACYLATED FORM; HYDROLYSIS | SANYO SHOKUHIN CO., LTD. (JP) | 2001-04-17 | — | — | US | disclosed |
| CN-1289263-A | Method for separating substance mixtures using polysaccharides | AVANTIS RES & TECHNOLOGIES GMB (DE) | 2001-03-28 | — | — | CN | disclosed |
| US-6087513-A | REACTION OF ALLYL ARYL ETHER WITH HYDROGEN PEROXIDE IN THE PRESENCE OF TRANSITION METALS FOR OXIDATION | THE DOW CHEMICAL COMPANY (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0978567-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOLS | SANYO SHOKUHIN CO., LTD. (JP) | 2000-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078444-A1 | Fluorous triphase and other multiphase systems | NAF1, SLC29A1, PFAS | UGT2B7 1149/4885MEN1 350/4885KMT2A 2568/4885 |
| US-20160207932-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | COX6C, CBR3, CYCS | UGT2B7 3006/4885MEN1 2805/4885KMT2A 2171/4885 |
| US-20010039354-A1 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | DRD4, PNMT, DRD1 | UGT2B7 3531/4885MEN1 2356/4885KMT2A 2853/4885 |
| US-20030125590-A1 | Fluorous triphase and other multiphase systems | DDT, CNDP2, PFAS | UGT2B7 390/4885MEN1 602/4885KMT2A 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.